Ashfield Capital Partners, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ashfield Capital Partners, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2022$359,000
-10.2%
4,7270.0%0.03%
-3.2%
Q2 2022$400,000
-6.5%
4,727
-3.0%
0.03%
+10.7%
Q1 2022$428,000
+0.5%
4,8740.0%0.03%
+3.7%
Q4 2021$426,000
+7.3%
4,874
+0.5%
0.03%
-3.6%
Q3 2021$397,000
-16.4%
4,849
-6.9%
0.03%
-17.6%
Q2 2021$475,000
-17.1%
5,208
-22.3%
0.03%
-26.1%
Q1 2021$573,000
-9.5%
6,6990.0%0.05%
-9.8%
Q4 2020$633,000
+8.0%
6,699
-0.7%
0.05%
-3.8%
Q3 2020$586,000
-4.7%
6,744
-4.2%
0.05%
-13.1%
Q2 2020$615,000
-28.2%
7,037
-32.2%
0.06%
-41.3%
Q1 2020$856,000
-17.2%
10,383
-4.9%
0.10%
+1.0%
Q4 2019$1,034,000
+3.6%
10,923
-4.9%
0.10%
-4.6%
Q3 2019$998,000
-4.9%
11,4830.0%0.11%
-3.6%
Q2 2019$1,049,000
-17.7%
11,483
-13.4%
0.11%
-20.0%
Q1 2019$1,275,000
+3.7%
13,264
-7.5%
0.14%
-12.5%
Q4 2018$1,230,000
-8.7%
14,338
-8.3%
0.16%
+6.0%
Q3 2018$1,347,000
-24.2%
15,636
-33.6%
0.15%
-32.0%
Q2 2018$1,778,000
-6.9%
23,534
-0.4%
0.22%
-10.5%
Q1 2018$1,910,000
+31.1%
23,621
+36.1%
0.25%
+32.6%
Q4 2017$1,457,000
+12.7%
17,354
+15.2%
0.19%
+8.1%
Q3 2017$1,293,000
+2.8%
15,066
-0.0%
0.17%
+0.6%
Q2 2017$1,258,000
-8.6%
15,072
-18.7%
0.17%
-9.9%
Q1 2017$1,377,000
-6.1%
18,540
-7.9%
0.19%
+32.6%
Q4 2016$1,466,000
-42.6%
20,124
-37.8%
0.14%
-31.4%
Q3 2016$2,553,000
-12.2%
32,334
-8.3%
0.21%
-10.3%
Q2 2016$2,909,000
-69.7%
35,258
-73.4%
0.23%
-66.4%
Q1 2016$9,615,000
-52.2%
132,735
-43.2%
0.70%
-49.3%
Q4 2015$20,097,000
-30.4%
233,573
-25.7%
1.37%
-26.0%
Q3 2015$28,890,000
-14.1%
314,293
-8.1%
1.86%
+0.6%
Q2 2015$33,626,000
+21.7%
341,935
+22.1%
1.84%
+25.4%
Q1 2015$27,624,000
-8.3%
280,132
-13.8%
1.47%
+1.1%
Q4 2014$30,110,000
+1111.7%
324,951
+1131.0%
1.46%
+1102.5%
Q3 2014$2,485,000
+5.3%
26,397
+1.2%
0.12%
+9.0%
Q2 2014$2,360,000
+0.4%
26,072
-5.7%
0.11%
-1.8%
Q1 2014$2,351,000
+4.7%
27,658
-1.0%
0.11%
+5.6%
Q4 2013$2,246,000
+5.8%
27,940
+1.0%
0.11%
-2.7%
Q3 2013$2,122,000
+8.1%
27,661
-0.4%
0.11%
+3.8%
Q2 2013$1,963,00027,7640.11%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders